{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:45:28Z","timestamp":1793497528619,"version":"4.5.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This review highlights the role of Anti-M\u00fcllerian Hormone (AMH) in ovarian insufficiency and as a predictor of menopause. AMH, produced by granulosa cells in growing follicles, is a key marker of ovarian reserve, reflecting the remaining pool of viable follicles. In cases of primary ovarian insufficiency (POI), AMH levels are significantly reduced, aiding in diagnosis and distinguishing POI from other causes of amenorrhea. AMH levels below 8\u2009pmol\/L have shown high sensitivity (85%) and specificity (100%) for diagnosing POI in women with secondary oligomenorrhea. Regarding ovarian aging, AMH declines steadily with age, serving as a reliable predictor of menopausal timing. AMH levels are linked to menopausal symptoms, particularly vasomotor symptoms like hot flashes and their severity. However, its reliability for diagnosing menopause is inconsistent, especially in younger populations or when determining the exact onset. AMH levels can predict an earlier onset of menopause with limited sensitivity and specificity, particularly when using age-specific concentrations, as lower age-specific AMH levels are associated with an earlier menopause onset. Tracking AMH over time can improve the prediction of menopause. The accuracy of AMH measurements can be enhanced when considered alongside other hormonal markers or clinical symptoms. In polycystic ovary syndrome (PCOS), elevated AMH levels suggest a delayed onset of menopause, indicating an approximately two-year longer reproductive lifespan compared to women without PCOS (mean menopause age: 51.4 years in PCOS cases vs. 49.7 years in healthy controls). In endometriosis, AMH levels generally decline after surgery; however, they remain stable after chemotherapy, even years later, indicating that the decline in ovarian reserve may not be significantly affected.<\/jats:p>","DOI":"10.1007\/s12020-025-04265-0","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:59:37Z","timestamp":1748005177000},"page":"338-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The role of anti-M\u00fcllerian hormone: insights into ovarian reserve, primary ovarian insufficiency, and menopause prediction"],"prefix":"10.1007","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2938-0889","authenticated-orcid":false,"given":"Eleftheria","family":"Karaviti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2220-1152","authenticated-orcid":false,"given":"Dimitra","family":"Karaviti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6549-9002","authenticated-orcid":false,"given":"Eleni-Rafaela","family":"Kani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathia","family":"Chatziandreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-1376","authenticated-orcid":false,"given":"Stavroula A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-9716","authenticated-orcid":false,"given":"Theodora","family":"Psaltopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0590-1575","authenticated-orcid":false,"given":"Sophia","family":"Kalantaridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1488-2668","authenticated-orcid":false,"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"5","key":"4265_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/rep.0.1240601","volume":"124","author":"ALL Durlinger","year":"2002","unstructured":"A.L.L. Durlinger, J.A. Visser, A.P.N. Themmen, Regulation of ovarian function: the role of anti-m\u00fcllerian hormone. Reproduction 124(5), 601\u2013609 (2002). https:\/\/doi.org\/10.1530\/rep.0.1240601.","journal-title":"Reproduction"},{"issue":"2","key":"4265_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/molehr\/gah015","volume":"10","author":"C Weenen","year":"2004","unstructured":"C. Weenen, J.S.E. Laven, A.R.M. Von Bergh, M. Cranfield, N.P. Groome, J.A. Visser, P. Kramer, B.C.J.M. Fauser, A.P.N. Themmen, Anti-m\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol. Hum. Reprod. 10(2), 77\u201383 (2004). https:\/\/doi.org\/10.1093\/molehr\/gah015.","journal-title":"Mol. Hum. Reprod."},{"issue":"4","key":"4265_CR3","first-page":"347","volume":"3","author":"N Josso","year":"2006","unstructured":"N. Josso, J.Y. Picard, R. Rey, N. di Clemente, Testicular anti-m\u00fcllerian hormone: history, genetics, regulation and clinical applications. Pediatric Endocrinol. Rev.: PER 3(4), 347\u2013358 (2006).","journal-title":"Pediatric Endocrinol. Rev.: PER"},{"issue":"6","key":"4265_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/endrev\/bnab012","volume":"42","author":"N di Clemente","year":"2021","unstructured":"N. di Clemente, C. Racine, A. Pierre, J. Taieb, Anti-m\u00fcllerian hormone in female reproduction. Endocr. Rev. 42(6), 753\u2013782 (2021). https:\/\/doi.org\/10.1210\/endrev\/bnab012.","journal-title":"Endocr. Rev."},{"issue":"9","key":"4265_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1089\/dna.2004.23.572","volume":"23","author":"C Lasala","year":"2004","unstructured":"C. Lasala, D. Carr\u00e9-Eus\u00e8be, J.-Y. Picard, R. Rey, Subcellular and molecular mechanisms regulating anti-m\u00fcllerian hormone gene expression in mammalian and nonmammalian species. DNA Cell Biol. 23(9), 572\u2013585 (2004). https:\/\/doi.org\/10.1089\/dna.2004.23.572.","journal-title":"DNA Cell Biol."},{"key":"4265_CR6","doi-asserted-by":"publisher","unstructured":"M. Pannetier, A.-A. Chassot, M.-C. Chaboissier, E. Pailhoux, Involvement of FOXL2 and RSPO1 in Ovarian Determination, Development, and Maintenance in Mammals. Sex. Dev. 10(4), 167\u2013184 (2016). https:\/\/doi.org\/10.1159\/000448667.","DOI":"10.1159\/000448667"},{"issue":"3","key":"4265_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/mrd.20208","volume":"70","author":"NA Salmon","year":"2005","unstructured":"N.A. Salmon, A.H. Handyside, I.M. Joyce, Expression of Sox8, Sf1, Gata4, Wt1, Dax1, and Fog2 in the mouse ovarian follicle: implications for the regulation of Amh expression. Mol. Reprod. Dev. 70(3), 271\u2013277 (2005). https:\/\/doi.org\/10.1002\/mrd.20208.","journal-title":"Mol. Reprod. Dev."},{"issue":"3","key":"4265_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s0092-8674(00)81172-1","volume":"93","author":"MW Nachtigal","year":"1998","unstructured":"M.W. Nachtigal, Y. Hirokawa, D.L. Enyeart-VanHouten, J.N. Flanagan, G.D. Hammer, H.A. Ingraham, Wilms\u2019 tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93(3), 445\u2013454 (1998). https:\/\/doi.org\/10.1016\/s0092-8674(00)81172-1.","journal-title":"Cell"},{"issue":"6","key":"4265_CR9","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2009.11.021","volume":"139","author":"NH Uhlenhaut","year":"2009","unstructured":"N.H. Uhlenhaut, S. Jakob, K. Anlag, T. Eisenberger, R. Sekido, J. Kress, A.-C. Treier, C. Klugmann, C. Klasen, N.I. Holter, D. Riethmacher, G. Sch\u00fctz, A.J. Cooney, R. Lovell-Badge, M. Treier, Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 139(6), 1130\u20131142 (2009). https:\/\/doi.org\/10.1016\/j.cell.2009.11.021.","journal-title":"Cell"},{"issue":"2","key":"4265_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1210\/en.2011-1347","volume":"153","author":"P Bernard","year":"2012","unstructured":"P. Bernard, J. Ryan, H. Sim, D.P. Czech, A.H. Sinclair, P. Koopman, V.R. Harley, Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer. Endocrinology 153(2), 901\u2013912 (2012). https:\/\/doi.org\/10.1210\/en.2011-1347.","journal-title":"Endocrinology"},{"issue":"3","key":"4265_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.fertnstert.2014.05.031","volume":"102","author":"M Park","year":"2014","unstructured":"M. Park, D.-S. Suh, K. Lee, J. Bae, Positive cross talk between FOXL2 and antim\u00fcllerian hormone regulates ovarian reserve. Fertil. Steril. 102(3), 847\u2013855.e1 (2014). https:\/\/doi.org\/10.1016\/j.fertnstert.2014.05.031.","journal-title":"Fertil. Steril."},{"issue":"7","key":"4265_CR12","doi-asserted-by":"publisher","first-page":"e0159112","DOI":"10.1371\/journal.pone.0159112","volume":"11","author":"H Jin","year":"2016","unstructured":"H. Jin, M. Won, S.E. Park, S. Lee, M. Park, J. Bae, FOXL2 is an essential activator of SF-1-induced transcriptional regulation of anti-m\u00fcllerian hormone in human granulosa cells. PLoS One 11(7), e0159112 (2016). https:\/\/doi.org\/10.1371\/journal.pone.0159112.","journal-title":"PLoS One"},{"issue":"24","key":"4265_CR13","doi-asserted-by":"publisher","first-page":"13831","DOI":"10.1073\/pnas.96.24.13831","volume":"96","author":"J Teixeira","year":"1999","unstructured":"J. Teixeira, D.J. Kehas, R. Antun, P.K. Donahoe, Transcriptional regulation of the rat m\u00fcllerian inhibiting substance type II receptor in rodent leydig cells. Proc. Natl Acad. Sci. USA 96(24), 13831\u201313838 (1999). https:\/\/doi.org\/10.1073\/pnas.96.24.13831.","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"45","key":"4265_CR14","doi-asserted-by":"publisher","first-page":"29654","DOI":"10.1074\/jbc.273.45.29654","volume":"273","author":"P de Santa Barbara","year":"1998","unstructured":"P. de Santa Barbara, B. Moniot, F. Poulat, B. Boizet, P. Berta, Steroidogenic factor-1 regulates transcription of the human anti-m\u00fcllerian hormone receptor. J. Biol. Chem. 273(45), 29654\u201329660 (1998). https:\/\/doi.org\/10.1074\/jbc.273.45.29654.","journal-title":"J. Biol. Chem."},{"issue":"12","key":"4265_CR15","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1128\/MCB.01780-06","volume":"27","author":"J Klattig","year":"2007","unstructured":"J. Klattig, R. Sierig, D. Kruspe, B. Besenbeck, C. Englert, Wilms\u2019 tumor protein Wt1 is an activator of the anti-m\u00fcllerian hormone receptor gene Amhr2. Mol. Cell. Biol. 27(12), 4355\u20134364 (2007). https:\/\/doi.org\/10.1128\/MCB.01780-06.","journal-title":"Mol. Cell. Biol."},{"issue":"29","key":"4265_CR16","doi-asserted-by":"publisher","first-page":"26511","DOI":"10.1074\/jbc.M300804200","volume":"278","author":"A Hossain","year":"2003","unstructured":"A. Hossain, G.F. Saunders, Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the mullerian inhibiting substance type II receptor. J. Biol. Chem. 278(29), 26511\u201326516 (2003). https:\/\/doi.org\/10.1074\/jbc.M300804200.","journal-title":"J. Biol. Chem."},{"issue":"11","key":"4265_CR17","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1210\/en.2017-00619","volume":"158","author":"AP Kimura","year":"2017","unstructured":"A.P. Kimura, R. Yoneda, M. Kurihara, S. Mayama, S. Matsubara, A long noncoding RNA, lncRNA-Amhr2, plays a role in Amhr2 gene activation in mouse ovarian granulosa cells. Endocrinology 158(11), 4105\u20134121 (2017). https:\/\/doi.org\/10.1210\/en.2017-00619.","journal-title":"Endocrinology"},{"issue":"1","key":"4265_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.fertnstert.2008.04.047","volume":"92","author":"DA Dumesic","year":"2009","unstructured":"D.A. Dumesic, T.G. Lesnick, J.P. Stassart, G.D. Ball, A. Wong, D.H. Abbott, Intrafollicular antim\u00fcllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog\/recombinant human FSH therapy for in vitro fertilization and embryo transfer. Fertil. Steril. 92(1), 217\u2013221 (2009). https:\/\/doi.org\/10.1016\/j.fertnstert.2008.04.047.","journal-title":"Fertil. Steril."},{"issue":"2","key":"4265_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/humrep\/deg043","volume":"18","author":"R Fanchin","year":"2003","unstructured":"R. Fanchin, L.M. Schon\u00e4uer, C. Righini, N. Frydman, R. Frydman, J. Taieb, Serum anti-m\u00fcllerian hormone dynamics during controlled ovarian hyperstimulation. Hum. Reprod. 18(2), 328\u2013332 (2003). https:\/\/doi.org\/10.1093\/humrep\/deg043.","journal-title":"Hum. Reprod."},{"issue":"1","key":"4265_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/humrep\/dey339","volume":"34","author":"L Maione","year":"2019","unstructured":"L. Maione, A. F\u00e8vre, I.C. Nettore, A. Manilall, B. Francou, S. Trabado, J. Bouligand, A. Guiochon-Mantel, B. Delemer, C.A. Flanagan, P.E. Macchia, R.P. Millar, J. Young, Similarities and differences in the reproductive phenotypes of women with congenital hypogonadotrophic hypogonadism caused by GNRHR mutations and women with polycystic ovary syndrome. Hum. Reprod. 34(1), 137\u2013147 (2019). https:\/\/doi.org\/10.1093\/humrep\/dey339.","journal-title":"Hum. Reprod."},{"issue":"3","key":"4265_CR21","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/humrep\/des460","volume":"28","author":"A Pierre","year":"2013","unstructured":"A. Pierre, M. Peign\u00e9, M. Grynberg, N. Arouche, J. Taieb, L. Hesters, J. Gonzal\u00e8s, J.-Y. Picard, D. Dewailly, R. Fanchin, S. Catteau-Jonard, N. di Clemente, Loss of LH-induced down-regulation of anti-m\u00fcllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Hum. Reprod. 28(3), 762\u2013769 (2013). https:\/\/doi.org\/10.1093\/humrep\/des460.","journal-title":"Hum. Reprod."},{"issue":"1","key":"4265_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/jc.2006-1582","volume":"92","author":"L Pellatt","year":"2007","unstructured":"L. Pellatt, L. Hanna, M. Brincat, R. Galea, H. Brain, S. Whitehead, H. Mason, Granulosa cell production of anti-m\u00fcllerian hormone is increased in polycystic ovaries. J. Clin. Endocrinol. Metab. 92(1), 240\u2013245 (2007). https:\/\/doi.org\/10.1210\/jc.2006-1582.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4265_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12020-009-9227-6","volume":"36","author":"N Crisosto","year":"2009","unstructured":"N. Crisosto, T. Sir-Petermann, M. Greiner, M. Maliqueo, M. Moreno, P. Aedo, H.E. Lara, Testosterone-induced downregulation of anti-m\u00fcllerian hormone expression in granulosa cells from small bovine follicles. Endocrine 36(2), 339\u2013345 (2009). https:\/\/doi.org\/10.1007\/s12020-009-9227-6.","journal-title":"Endocrine"},{"issue":"9","key":"4265_CR24","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1210\/endo.140.9.6965","volume":"140","author":"SC Sharma","year":"1999","unstructured":"S.C. Sharma, J.W. Clemens, M.D. Pisarska, J.S. Richards, Expression and function of estrogen receptor subtypes in granulosa cells: regulation by estradiol and forskolin. Endocrinology 140(9), 4320\u20134334 (1999). https:\/\/doi.org\/10.1210\/endo.140.9.6965.","journal-title":"Endocrinology"},{"issue":"2","key":"4265_CR25","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.16502","volume":"12","author":"F Ramezani Tehrani","year":"2014","unstructured":"F. Ramezani Tehrani, M. Noroozzadeh, S. Zahediasl, A. Piryaei, S. Hashemi, F. Azizi, The time of prenatal androgen exposure affects development of polycystic ovary syndrome-like phenotype in adulthood in female rats. Int. J. Endocrinol. Metab. 12(2), e16502 (2014). https:\/\/doi.org\/10.5812\/ijem.16502.","journal-title":"Int. J. Endocrinol. Metab."},{"issue":"6","key":"4265_CR26","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00018-019-03230-1","volume":"77","author":"D Monniaux","year":"2020","unstructured":"D. Monniaux, C. Gen\u00eat, V. Maillard, P. Jarrier, H. Adriaensen, C. Hennequet-Antier, A.-L. Lain\u00e9, C. Laclie, P. Papillier, F. Plisson-Petit, A. Estienne, J. Cogni\u00e9, N. di Clemente, R. Dalbies-Tran, S. Fabre, Prenatal programming by testosterone of follicular theca cell functions in ovary. Cell. Mol. Life Sci.: CMLS 77(6), 1177\u20131196 (2020). https:\/\/doi.org\/10.1007\/s00018-019-03230-1.","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"issue":"3","key":"4265_CR27","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.fertnstert.2011.12.028","volume":"97","author":"A Veiga-Lopez","year":"2012","unstructured":"A. Veiga-Lopez, W. Ye, V. Padmanabhan, Developmental programming: prenatal testosterone excess disrupts anti-m\u00fcllerian hormone expression in preantral and antral follicles. Fertil. Steril. 97(3), 748\u2013756 (2012). https:\/\/doi.org\/10.1016\/j.fertnstert.2011.12.028.","journal-title":"Fertil. Steril."},{"issue":"1","key":"4265_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1210\/en.2014-1551","volume":"156","author":"A Estienne","year":"2015","unstructured":"A. Estienne, A. Pierre, N. di Clemente, J.-Y. Picard, P. Jarrier, C. Mansanet, D. Monniaux, S. Fabre, Anti-m\u00fcllerian hormone regulation by the bone morphogenetic proteins in the sheep ovary: deciphering a direct regulatory pathway. Endocrinology 156(1), 301\u2013313 (2015). https:\/\/doi.org\/10.1210\/en.2014-1551.","journal-title":"Endocrinology"},{"key":"4265_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.theriogenology.2018.05.032","volume":"118","author":"Z Zhao","year":"2018","unstructured":"Z. Zhao, F. Guo, X. Sun, Q. He, Z. Dai, X. Chen, Y. Zhao, J. Wang, BMP15 regulates AMH expression via the p38 MAPK pathway in granulosa cells from goat. Theriogenology 118, 72\u201379 (2018). https:\/\/doi.org\/10.1016\/j.theriogenology.2018.05.032.","journal-title":"Theriogenology"},{"issue":"5","key":"4265_CR30","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.theriogenology.2016.04.078","volume":"86","author":"DH Poole","year":"2016","unstructured":"D.H. Poole, O.M. Oc\u00f3n-Grove, A.L. Johnson, Anti-m\u00fcllerian hormone (AMH) receptor type II expression and AMH activity in bovine granulosa cells. Theriogenology 86(5), 1353\u20131360 (2016). https:\/\/doi.org\/10.1016\/j.theriogenology.2016.04.078.","journal-title":"Theriogenology"},{"issue":"6","key":"4265_CR31","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1210\/jc.2015-4066","volume":"101","author":"A Pierre","year":"2016","unstructured":"A. Pierre, A. Estienne, C. Racine, J.-Y. Picard, R. Fanchin, B. Lahoz, J.L. Alabart, J. Folch, P. Jarrier, S. Fabre, D. Monniaux, N. di Clemente, The bone morphogenetic protein 15 Up-regulates the anti-m\u00fcllerian hormone receptor expression in granulosa cells. J. Clin. Endocrinol. Metab. 101(6), 2602\u20132611 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4066.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4265_CR32","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/humrep\/det072","volume":"28","author":"Z Merhi","year":"2013","unstructured":"Z. Merhi, E. Buyuk, D.S. Berger, A. Zapantis, D.D. Israel, S. Chua, S. Jindal, Leptin suppresses anti-mullerian hormone gene expression through the JAK2\/STAT3 pathway in luteinized granulosa cells of women undergoing IVF. Hum. Reprod. 28(6), 1661\u20131669 (2013). https:\/\/doi.org\/10.1093\/humrep\/det072.","journal-title":"Hum. Reprod."},{"issue":"1","key":"4265_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.fertnstert.2018.09.022","volume":"111","author":"XY Liu","year":"2019","unstructured":"X.Y. Liu, Y.J. Yang, C.L. Tang, K. Wang, J.-J. Chen, X.M. Teng, Y.C. Ruan, J.Z. Yang, Elevation of antim\u00fcllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin. Fertil. Steril. 111(1), 157\u2013167 (2019). https:\/\/doi.org\/10.1016\/j.fertnstert.2018.09.022.","journal-title":"Fertil. Steril."},{"key":"4265_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.gene.2017.08.028","volume":"633","author":"X Ding","year":"2017","unstructured":"X. Ding, X. Kou, Y. Zhang, X. Zhang, G. Cheng, T. Jia, Leptin siRNA promotes ovarian granulosa cell apoptosis and affects steroidogenesis by increasing NPY2 receptor expression. Gene 633, 28\u201334 (2017). https:\/\/doi.org\/10.1016\/j.gene.2017.08.028.","journal-title":"Gene"},{"key":"4265_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-72","volume":"15","author":"C Glister","year":"2014","unstructured":"C. Glister, N. Hatzirodos, K. Hummitzsch, P.G. Knight, R.J. Rodgers, The global effect of follicle-stimulating hormone and tumour necrosis factor \u03b1 on gene expression in cultured bovine ovarian granulosa cells. BMC Genomics 15, 72 (2014). https:\/\/doi.org\/10.1186\/1471-2164-15-72.","journal-title":"BMC Genomics"},{"issue":"6","key":"4265_CR36","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.3892\/mmr.2016.5173","volume":"13","author":"Y Fang","year":"2016","unstructured":"Y. Fang, X. Lu, L. Liu, X. Lin, M. Sun, J. Fu, S. Xu, Y. Tan, Vascular endothelial growth factor induces anti\u2011m\u00fcllerian hormone receptor 2 overexpression in ovarian granulosa cells of in vitro fertilization\/intracytoplasmic sperm injection patients. Mol. Med. Rep. 13(6), 5157\u20135162 (2016). https:\/\/doi.org\/10.3892\/mmr.2016.5173.","journal-title":"Mol. Med. Rep."},{"key":"4265_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gene.2018.10.006","volume":"683","author":"T Wang","year":"2019","unstructured":"T. Wang, Y. Liu, M. Lv, Q. Xing, Z. Zhang, X. He, Y. Xu, Z. Wei, Y. Cao, miR-323-3p regulates the steroidogenesis and cell apoptosis in polycystic ovary syndrome (PCOS) by targeting IGF-1. Gene 683, 87\u2013100 (2019). https:\/\/doi.org\/10.1016\/j.gene.2018.10.006.","journal-title":"Gene"},{"key":"4265_CR38","doi-asserted-by":"publisher","unstructured":"C.J. Mark-Kappeler, N. Sen, A.F. Keating, I. G. Sipes, P.B. Hoyer, Distribution and responsiveness of rat anti-M\u00fcllerian hormone during ovarian development and VCD-induced ovotoxicity. Toxicol. Appl. Pharmacol. 249(1), 1\u20137 (2010). https:\/\/doi.org\/10.1016\/j.taap.2010.08.024.","DOI":"10.1016\/j.taap.2010.08.024"},{"key":"4265_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mce.2018.09.004","volume":"479","author":"Z Merhi","year":"2019","unstructured":"Z. Merhi, Vitamin D attenuates the effect of advanced glycation end products on anti-mullerian hormone signaling. Mol. Cell. Endocrinol. 479, 87\u201392 (2019). https:\/\/doi.org\/10.1016\/j.mce.2018.09.004.","journal-title":"Mol. Cell. Endocrinol."},{"key":"4265_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cca.2017.11.027","volume":"476","author":"SZ Shahrokhi","year":"2018","unstructured":"S.Z. Shahrokhi, F. Kazerouni, F. Ghaffari, Anti-m\u00fcllerian hormone: genetic and environmental effects. Clinica Chim. Acta; Int. J. Clin. Chem. 476, 123\u2013129 (2018). https:\/\/doi.org\/10.1016\/j.cca.2017.11.027.","journal-title":"Clinica Chim. Acta; Int. J. Clin. Chem."},{"issue":"1","key":"4265_CR41","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3892\/mmr.2018.8989","volume":"18","author":"X-Y Fu","year":"2018","unstructured":"X.-Y. Fu, H.-H. Chen, N. Zhang, M.-X. Ding, Y.-E. Qiu, X.-M. Pan, Y.-S. Fang, Y.-P. Lin, Q. Zheng, W.-Q. Wang, Effects of chronic unpredictable mild stress on ovarian reserve in female rats: feasibility analysis of a rat model of premature ovarian failure. Mol. Med. Rep. 18(1), 532\u2013540 (2018). https:\/\/doi.org\/10.3892\/mmr.2018.8989.","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"4265_CR42","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jogn.2016.06.012","volume":"45","author":"TM Hardy","year":"2016","unstructured":"T.M. Hardy, D.O. McCarthy, N.H. Fourie, W.A. Henderson, Anti-m\u00fcllerian hormone levels and urinary cortisol in women with chronic abdominal pain. J. Obstet., Gynecologic, Neonatal Nurs.: JOGNN 45(6), 772\u2013780 (2016). https:\/\/doi.org\/10.1016\/j.jogn.2016.06.012.","journal-title":"J. Obstet., Gynecologic, Neonatal Nurs.: JOGNN"},{"issue":"9","key":"4265_CR43","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1093\/humrep\/del165","volume":"21","author":"IB Carlsson","year":"2006","unstructured":"I.B. Carlsson, J.E. Scott, J.A. Visser, O. Ritvos, A.P.N. Themmen, O. Hovatta, Anti-m\u00fcllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum. Reprod. 21(9), 2223\u20132227 (2006). https:\/\/doi.org\/10.1093\/humrep\/del165.","journal-title":"Hum. Reprod."},{"issue":"3","key":"4265_CR44","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","volume":"143","author":"ALL Durlinger","year":"2002","unstructured":"A.L.L. Durlinger, M.J.G. Gruijters, P. Kramer, B. Karels, H.A. Ingraham, M.W. Nachtigal, J.T.J. Uilenbroek, J.A. Grootegoed, A.P.N. Themmen, Anti-m\u00fcllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143(3), 1076\u20131084 (2002). https:\/\/doi.org\/10.1210\/endo.143.3.8691.","journal-title":"Endocrinology"},{"issue":"12","key":"4265_CR45","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","volume":"140","author":"AL Durlinger","year":"1999","unstructured":"A.L. Durlinger, P. Kramer, B. Karels, F.H. de Jong, J.T. Uilenbroek, J.A. Grootegoed, A.P. Themmen, Control of primordial follicle recruitment by anti-m\u00fcllerian hormone in the mouse ovary. Endocrinology 140(12), 5789\u20135796 (1999). https:\/\/doi.org\/10.1210\/endo.140.12.7204.","journal-title":"Endocrinology"},{"issue":"11","key":"4265_CR46","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","volume":"142","author":"AL Durlinger","year":"2001","unstructured":"A.L. Durlinger, M.J. Gruijters, P. Kramer, B. Karels, T.R. Kumar, M.M. Matzuk, U.M. Rose, F.H. de Jong, J.T. Uilenbroek, J.A. Grootegoed, A.P. Themmen, Anti-m\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142(11), 4891\u20134899 (2001). https:\/\/doi.org\/10.1210\/endo.142.11.8486.","journal-title":"Endocrinology"},{"issue":"1","key":"4265_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2014-1020","volume":"36","author":"AJW Hsueh","year":"2015","unstructured":"A.J.W. Hsueh, K. Kawamura, Y. Cheng, B.C.J.M. Fauser, Intraovarian control of early folliculogenesis. Endocr. Rev. 36(1), 1\u201324 (2015). https:\/\/doi.org\/10.1210\/er.2014-1020.","journal-title":"Endocr. Rev."},{"issue":"1","key":"4265_CR48","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1073\/pnas.0506736102","volume":"103","author":"H Shiina","year":"2006","unstructured":"H. Shiina, T. Matsumoto, T. Sato, K. Igarashi, J. Miyamoto, S. Takemasa, M. Sakari, I. Takada, T. Nakamura, D. Metzger, P. Chambon, J. Kanno, H. Yoshikawa, S. Kato, Premature ovarian failure in androgen receptor-deficient mice. Proc. Natl Acad. Sci. USA 103(1), 224\u2013229 (2006). https:\/\/doi.org\/10.1073\/pnas.0506736102.","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"2","key":"4265_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1095\/biolreprod.105.047407","volume":"75","author":"W Luo","year":"2006","unstructured":"W. Luo, M.C. Wiltbank, Distinct regulation by steroids of messenger RNAs for FSHR and CYP19A1 in bovine granulosa cells. Biol. Reprod. 75(2), 217\u2013225 (2006). https:\/\/doi.org\/10.1095\/biolreprod.105.047407.","journal-title":"Biol. Reprod."},{"issue":"11","key":"4265_CR50","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1210\/endo.142.11.8482","volume":"142","author":"H Wang","year":"2001","unstructured":"H. Wang, K. Andoh, H. Hagiwara, L. Xiaowei, N. Kikuchi, Y. Abe, K. Yamada, R. Fatima, H. Mizunuma, Effect of adrenal and ovarian androgens on type 4 follicles unresponsive to FSH in immature mice. Endocrinology 142(11), 4930\u20134936 (2001). https:\/\/doi.org\/10.1210\/endo.142.11.8482.","journal-title":"Endocrinology"},{"issue":"8","key":"4265_CR51","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","volume":"84","author":"S Weil","year":"1999","unstructured":"S. Weil, K. Vendola, J. Zhou, C.A. Bondy, Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J. Clin. Endocrinol. Metab. 84(8), 2951\u20132956 (1999). https:\/\/doi.org\/10.1210\/jcem.84.8.5929.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4265_CR52","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","volume":"96","author":"L Pellatt","year":"2011","unstructured":"L. Pellatt, S. Rice, N. Dilaver, A. Heshri, R. Galea, M. Brincat, K. Brown, E.R. Simpson, H.D. Mason, Anti-m\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil. Steril. 96(5), 1246\u20131251.e1 (2011). https:\/\/doi.org\/10.1016\/j.fertnstert.2011.08.015.","journal-title":"Fertil. Steril."},{"issue":"12","key":"4265_CR53","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/molehr\/gat065","volume":"19","author":"M Lebbe","year":"2013","unstructured":"M. Lebbe, T.K. Woodruff, Involvement of androgens in ovarian health and disease. Mol. Hum. Reprod. 19(12), 828\u2013837 (2013). https:\/\/doi.org\/10.1093\/molehr\/gat065.","journal-title":"Mol. Hum. Reprod."},{"issue":"8","key":"4265_CR54","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/humrep\/dev131","volume":"30","author":"M\u0160 Alebi\u0107","year":"2015","unstructured":"M.\u0160 Alebi\u0107, N. Stojanovi\u0107, A. Duhamel, D. Dewailly, The phenotypic diversity in per-follicle anti-m\u00fcllerian hormone production in polycystic ovary syndrome. Hum. Reprod. 30(8), 1927\u20131933 (2015). https:\/\/doi.org\/10.1093\/humrep\/dev131.","journal-title":"Hum. Reprod."},{"issue":"12","key":"4265_CR55","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1210\/jc.2003-030727","volume":"88","author":"P Pigny","year":"2003","unstructured":"P. Pigny, E. Merlen, Y. Robert, C. Cortet-Rudelli, C. Decanter, S. Jonard, D. Dewailly, Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J. Clin. Endocrinol. Metab. 88(12), 5957\u20135962 (2003). https:\/\/doi.org\/10.1210\/jc.2003-030727.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4265_CR56","doi-asserted-by":"publisher","unstructured":"C. Stocco, Aromatase expression in the ovary: Hormonal and molecular regulation. Steroids 73(5), 473\u2013487 (2008). https:\/\/doi.org\/10.1016\/j.steroids.2008.01.017.","DOI":"10.1016\/j.steroids.2008.01.017"},{"issue":"3","key":"4265_CR57","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1242\/dev.114.3.721","volume":"114","author":"N di Clemente","year":"1992","unstructured":"N. di Clemente, S. Ghaffari, R.B. Pepinsky, C. Pieau, N. Josso, R.L. Cate, B. Vigier, A quantitative and interspecific test for biological activity of anti-m\u00fcllerian hormone: the fetal ovary aromatase assay. Development 114(3), 721\u2013727 (1992). https:\/\/doi.org\/10.1242\/dev.114.3.721.","journal-title":"Development"},{"key":"4265_CR58","doi-asserted-by":"publisher","unstructured":"R. Fanchin, L.M. Schon\u00e4uer, C. Righini, N. Frydman, R. Frydman, J. Taieb, Serum anti-M\u00fcllerian hormone dynamics during controlled ovarian hyperstimulation. Hum. Reprod. (Oxford, England) 18(2), 328\u2013332 (2003). https:\/\/doi.org\/10.1093\/humrep\/deg043.","DOI":"10.1093\/humrep\/deg043"},{"issue":"4","key":"4265_CR59","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1210\/endo-127-4-1825","volume":"127","author":"T Kuroda","year":"1990","unstructured":"T. Kuroda, M.M. Lee, C.M. Haqq, D.M. Powell, T.F. Manganaro, P.K. Donahoe, Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes. Endocrinology 127(4), 1825\u20131832 (1990). https:\/\/doi.org\/10.1210\/endo-127-4-1825.","journal-title":"Endocrinology"},{"issue":"6","key":"4265_CR60","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1172\/JCI119653","volume":"100","author":"L Al-Attar","year":"1997","unstructured":"L. Al-Attar, K. No\u00ebl, M. Dutertre, C. Belville, M.G. Forest, P.S. Burgoyne, N. Josso, R. Rey, Hormonal and cellular regulation of sertoli cell anti-m\u00fcllerian hormone production in the postnatal mouse. J. Clin. Investig. 100(6), 1335\u20131343 (1997). https:\/\/doi.org\/10.1172\/JCI119653.","journal-title":"J. Clin. Investig."},{"issue":"7","key":"4265_CR61","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s10815-015-0494-2","volume":"32","author":"E Prapa","year":"2015","unstructured":"E. Prapa, A. Vasilaki, K. Dafopoulos, E. Katsiani, P. Georgoulias, C.I. Messini, G. Anifandis, I.E. Messinis, Effect of Anti-M\u00fcllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling. J. Assist. Reprod. Genet. 32(7), 1079\u20131088 (2015). https:\/\/doi.org\/10.1007\/s10815-015-0494-2.","journal-title":"J. Assist. Reprod. Genet."},{"issue":"5 Suppl","key":"4265_CR62","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.fertnstert.2007.03.066","volume":"89","author":"MP Grossman","year":"2008","unstructured":"M.P. Grossman, S.T. Nakajima, M.E. Fallat, Y. Siow, M\u00fcllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil. Steril. 89(5 Suppl), 1364\u20131370 (2008). https:\/\/doi.org\/10.1016\/j.fertnstert.2007.03.066.","journal-title":"Fertil. Steril."},{"issue":"8","key":"4265_CR63","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/molehr\/gat024","volume":"19","author":"JV Jeppesen","year":"2013","unstructured":"J.V. Jeppesen, R.A. Anderson, T.W. Kelsey, S.L. Christiansen, S.G. Kristensen, K. Jayaprakasan, N. Raine-Fenning, B.K. Campbell, C. Yding Andersen, Which follicles make the most anti-mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol. Hum. Reprod. 19(8), 519\u2013527 (2013). https:\/\/doi.org\/10.1093\/molehr\/gat024.","journal-title":"Mol. Hum. Reprod."},{"key":"4265_CR64","doi-asserted-by":"publisher","unstructured":"S. Catteau-Jonard, P. Pigny, A.-C. Reyss, C. Decanter, E. Poncelet, D. Dewailly, Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 92(11), 4138\u20134143 (2007). https:\/\/doi.org\/10.1210\/jc.2007-0868.","DOI":"10.1210\/jc.2007-0868"},{"issue":"1","key":"4265_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgaa764","volume":"106","author":"N Santoro","year":"2021","unstructured":"N. Santoro, C. Roeca, B.A. Peters, G. Neal-Perry, The menopause transition: signs, symptoms, and management options. J. Clin. Endocrinol. Metab. 106(1), 1\u201315 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgaa764.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4265_CR66","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jsmc.2018.04.011","volume":"13","author":"FC Baker","year":"2018","unstructured":"F.C. Baker, L. Lampio, T. Saaresranta, P. Polo-Kantola, Sleep and sleep disorders in the menopausal transition. Sleep. Med. Clin. 13(3), 443\u2013456 (2018). https:\/\/doi.org\/10.1016\/j.jsmc.2018.04.011.","journal-title":"Sleep. Med. Clin."},{"key":"4265_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2022.03.003","volume":"81","author":"V Talaulikar","year":"2022","unstructured":"V. Talaulikar, Menopause transition: physiology and symptoms. Best. Pract. Res. Clin. Obstet. Gynaecol. 81, 3\u20137 (2022). https:\/\/doi.org\/10.1016\/j.bpobgyn.2022.03.003.","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"4265_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2024.108055","volume":"189","author":"SA Paschou","year":"2024","unstructured":"S.A. Paschou, K.I. Athanasiadou, T. Hafford-Letchfield, S. Hinchliff, M. Mauskar, M. Rees, J.A. Simon, E. Armeni, C.T. Erel, I. Fistonic, T. Hillard, A.L. Hirschberg, B. Meczekalski, N. Mendoza, A.O. Mueck, T. Simoncini, P. Stute, D. van Dijken, I. Lambrinoudaki, Sexual health and wellbeing and the menopause: an EMAS clinical guide. Maturitas 189, 108055 (2024). https:\/\/doi.org\/10.1016\/j.maturitas.2024.108055.","journal-title":"Maturitas"},{"issue":"4","key":"4265_CR69","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5114\/pm.2019.93117","volume":"18","author":"A Augoulea","year":"2019","unstructured":"A. Augoulea, M. Moros, N. Kokras, V. Karageorgiou, S.A. Paschou, R. Lymberi, K. Panoulis, G. Kaparos, A. Lykeridou, I. Lambrinoudaki, Association of menopausal symptoms with sociodemographic factors and personality traits. Prz. Menopauzalny = Menopause Rev. 18(4), 191\u2013197 (2019). https:\/\/doi.org\/10.5114\/pm.2019.93117.","journal-title":"Prz. Menopauzalny = Menopause Rev."},{"issue":"4","key":"4265_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/13697137.2020.1739642","volume":"23","author":"J Carugno","year":"2020","unstructured":"J. Carugno, Clinical management of vaginal bleeding in postmenopausal women. Climacteric: J. Int. Menopause Soc. 23(4), 343\u2013349 (2020). https:\/\/doi.org\/10.1080\/13697137.2020.1739642.","journal-title":"Climacteric: J. Int. Menopause Soc."},{"issue":"2","key":"4265_CR71","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ogc.2017.02.008","volume":"44","author":"JL Bacon","year":"2017","unstructured":"J.L. Bacon, The menopausal transition. Obstet. Gynecol. Clin. North. Am. 44(2), 285\u2013296 (2017). https:\/\/doi.org\/10.1016\/j.ogc.2017.02.008.","journal-title":"Obstet. Gynecol. Clin. North. Am."},{"issue":"1","key":"4265_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101774","volume":"38","author":"K Koysombat","year":"2024","unstructured":"K. Koysombat, P. McGown, S. Nyunt, A. Abbara, W.S. Dhillo, New advances in menopause symptom management. Best. Pract. Res. Clin. Endocrinol. Metab. 38(1), 101774 (2024). https:\/\/doi.org\/10.1016\/j.beem.2023.101774.","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"4265_CR73","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bpobgyn.2021.10.010","volume":"81","author":"B Patel","year":"2022","unstructured":"B. Patel, W.S. Dhillo, Menopause review: emerging treatments for menopausal symptoms. Best. Pract. Res. Clin. Obstet. Gynaecol. 81, 134\u2013144 (2022). https:\/\/doi.org\/10.1016\/j.bpobgyn.2021.10.010.","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"1","key":"4265_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101855","volume":"38","author":"C Gatenby","year":"2024","unstructured":"C. Gatenby, P. Simpson, Menopause: physiology, definitions, and symptoms. Best. Pract. Res. Clin. Endocrinol. Metab. 38(1), 101855 (2024). https:\/\/doi.org\/10.1016\/j.beem.2023.101855.","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"22","key":"4265_CR75","doi-asserted-by":"publisher","first-page":"12507","DOI":"10.3390\/ijms222212507","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"E. Rudnicka, M. Kunicki, A. Calik-Ksepka, K. Suchta, A. Duszewska, K. Smolarczyk, R. Smolarczyk, Anti-m\u00fcllerian hormone in pathogenesis, diagnostic and treatment of PCOS. Int. J. Mol. Sci. 22(22), 12507 (2021). https:\/\/doi.org\/10.3390\/ijms222212507.","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"4265_CR76","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/humrep\/der297","volume":"26","author":"D Dewailly","year":"2011","unstructured":"D. Dewailly, H. Gronier, E. Poncelet, G. Robin, M. Leroy, P. Pigny, A. Duhamel, S. Catteau-Jonard, Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum. Reprod. 26(11), 3123\u20133129 (2011). https:\/\/doi.org\/10.1093\/humrep\/der297.","journal-title":"Hum. Reprod."},{"key":"4265_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.733731","volume":"12","author":"AC de Kat","year":"2021","unstructured":"A.C. de Kat, F.J.M. Broekmans, C.B. Lambalk, Role of AMH in prediction of menopause. Front. Endocrinol. 12, 733731 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.733731.","journal-title":"Front. Endocrinol."},{"issue":"10","key":"4265_CR78","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41574-022-00708-0","volume":"18","author":"I Lambrinoudaki","year":"2022","unstructured":"I. Lambrinoudaki, S.A. Paschou, E. Armeni, D.G. Goulis, The interplay between diabetes mellitus and menopause: clinical implications. Nat. Rev. Endocrinol. 18(10), 608\u2013622 (2022). https:\/\/doi.org\/10.1038\/s41574-022-00708-0.","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"4265_CR79","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s13224-020-01362-0","volume":"70","author":"L Shrikhande","year":"2020","unstructured":"L. Shrikhande, B. Shrikhande, A. Shrikhande, AMH and its clinical implications. J. Obstet. Gynaecol. India 70(5), 337\u2013341 (2020). https:\/\/doi.org\/10.1007\/s13224-020-01362-0.","journal-title":"J. Obstet. Gynaecol. India"},{"issue":"23","key":"4265_CR80","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.3390\/jcm11237209","volume":"11","author":"N Russell","year":"2022","unstructured":"N. Russell, A. Gilmore, W.E. Roudebush, Clinical utilities of anti-m\u00fcllerian hormone. J. Clin. Med. 11(23), 7209 (2022). https:\/\/doi.org\/10.3390\/jcm11237209.","journal-title":"J. Clin. Med."},{"issue":"3","key":"4265_CR81","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/humupd\/dmac045","volume":"29","author":"SM Nelson","year":"2023","unstructured":"S.M. Nelson, S.R. Davis, S. Kalantaridou, M.A. Lumsden, N. Panay, R.A. Anderson, Anti-m\u00fcllerian hormone for the diagnosis and prediction of menopause: a systematic review. Hum. Reprod. Update 29(3), 327\u2013346 (2023). https:\/\/doi.org\/10.1093\/humupd\/dmac045.","journal-title":"Hum. Reprod. Update"},{"key":"4265_CR82","doi-asserted-by":"publisher","unstructured":"C. Kim, J.C. Slaughter, E.T. Wang, D. Appiah, P. Schreiner, B. Leader, R. Calderon-Margalit, B. Sternfeld, D. Siscovick, M. Wellons, Anti-M\u00fcllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years. Maturitas 102, 18\u201325 (2017). https:\/\/doi.org\/10.1016\/j.maturitas.2017.04.018.","DOI":"10.1016\/j.maturitas.2017.04.018"},{"issue":"1","key":"4265_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77871-9","volume":"10","author":"AG Soares","year":"2020","unstructured":"A.G. Soares, F. Kilpi, A. Fraser, S.M. Nelson, N. Sattar, P.I. Welsh, K. Tilling, D.A. Lawlor, Longitudinal changes in reproductive hormones through the menopause transition in the Avon Longitudinal Study of Parents and Children (ALSPAC). Sci. Rep. 10(1), 21258 (2020). https:\/\/doi.org\/10.1038\/s41598-020-77871-9.","journal-title":"Sci. Rep."},{"issue":"3","key":"4265_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/geriatrics8030057","volume":"8","author":"E Chatziandreou","year":"2023","unstructured":"E. Chatziandreou, A. Eustathiou, A. Augoulea, E. Armeni, N. Mili, I. Boutas, N. Tsoltos, A. Kapetanaki, S. Kalantaridou, Antim\u00fcllerian hormone as a tool to predict the age at menopause. Geriatrics 8(3), 57 (2023). https:\/\/doi.org\/10.3390\/geriatrics8030057.","journal-title":"Geriatrics"},{"issue":"1","key":"4265_CR85","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0378-5122(98)00025-5","volume":"29","author":"JG Greene","year":"1998","unstructured":"J.G. Greene, Constructing a standard climacteric scale. Maturitas 29(1), 25\u201331 (1998). https:\/\/doi.org\/10.1016\/s0378-5122(98)00025-5.","journal-title":"Maturitas"},{"key":"4265_CR86","unstructured":"Constructing a standard climacteric scale\u2014Maturitas (nd) Retrieved 26 September 2024, from https:\/\/wwwmaturitasorg\/article\/S0378-5122(98)00025-5\/abstract."},{"issue":"4","key":"4265_CR87","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000485917","volume":"94","author":"KE Cameron","year":"2018","unstructured":"K.E. Cameron, M.B. Kole, M.D. Sammel, J.P. Ginsberg, Y. Gosiengfiao, J.E. Mersereau, H.I. Su, C.R. Gracia, Acute menopausal symptoms in young cancer survivors immediately following chemotherapy. Oncology 94(4), 200\u2013206 (2018). https:\/\/doi.org\/10.1159\/000485917.","journal-title":"Oncology"},{"key":"4265_CR88","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.maturitas.2016.03.017","volume":"89","author":"T Dhanoya","year":"2016","unstructured":"T. Dhanoya, L.L. Sievert, S. Muttukrishna, K. Begum, T. Sharmeen, A. Kasim, O. Chowdhury, G.R. Bentley, Hot flushes and reproductive hormone levels during the menopausal transition. Maturitas 89, 43\u201351 (2016). https:\/\/doi.org\/10.1016\/j.maturitas.2016.03.017.","journal-title":"Maturitas"},{"issue":"5","key":"4265_CR89","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11764-020-00857-z","volume":"14","author":"A Chemerinski","year":"2020","unstructured":"A. Chemerinski, K. Cameron, M. Sammel, J. Ginsberg, C. Carlson, C. Gracia, Relationship of menopausal symptoms and ovarian reserve in reproductive-aged cancer survivors. J. Cancer Survivorship: Res. Pract. 14(5), 607\u2013613 (2020). https:\/\/doi.org\/10.1007\/s11764-020-00857-z.","journal-title":"J. Cancer Survivorship: Res. Pract."},{"issue":"2","key":"4265_CR90","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/s0015-0282(01)02993-4","volume":"77","author":"A de Vet","year":"2002","unstructured":"A. de Vet, J.S.E. Laven, F.H. de Jong, A.P.N. Themmen, B.C.J.M. Fauser, Antim\u00fcllerian hormone serum levels: a putative marker for ovarian aging. Fertil. Steril. 77(2), 357\u2013362 (2002). https:\/\/doi.org\/10.1016\/s0015-0282(01)02993-4.","journal-title":"Fertil. Steril."},{"issue":"1","key":"4265_CR91","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3346\/jkms.2008.23.1.104","volume":"23","author":"SY Shin","year":"2008","unstructured":"S.Y. Shin, J.R. Lee, G.W. Noh, H.J. Kim, W.J. Kang, S.H. Kim, J.-K. Chung, Analysis of serum levels of anti-m\u00fcllerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status. J. Korean Med. Sci. 23(1), 104\u2013110 (2008). https:\/\/doi.org\/10.3346\/jkms.2008.23.1.104.","journal-title":"J. Korean Med. Sci."},{"issue":"6","key":"4265_CR92","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1080\/13697137.2021.1965114","volume":"24","author":"J Zhang","year":"2021","unstructured":"J. Zhang, X. Wang, Z. Ren, S. Shao, Z. Hou, Z. Wang, J. Xi, W. Bai, Impact of age and menopausal stage on serum anti-m\u00fcllerian hormone levels in middle-aged women. Climacteric: J. Int. Menopause Soc. 24(6), 618\u2013623 (2021). https:\/\/doi.org\/10.1080\/13697137.2021.1965114.","journal-title":"Climacteric: J. Int. Menopause Soc."},{"issue":"4","key":"4265_CR93","doi-asserted-by":"publisher","first-page":"e1862","DOI":"10.1210\/clinem\/dgz283","volume":"105","author":"JS Finkelstein","year":"2020","unstructured":"J.S. Finkelstein, H. Lee, A. Karlamangla, R.M. Neer, P.M. Sluss, S.-A.M. Burnett-Bowie, K. Darakananda, P.K. Donahoe, S.D. Harlow, S.H. Prizand, H. Joffe, A. Kumar, D.E. Martin, D. McConnell, S. Merrilat, A. Morrison, L.M. Pastore, J.F. Randolph, G.A. Greendale, N. Santoro, Antimullerian hormone and impending menopause in late reproductive age: the study of women\u2019s health across the nation. J. Clin. Endocrinol. Metab. 105(4), e1862\u2013e1871 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz283.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4265_CR94","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/humrep\/dey077","volume":"33","author":"ER Bertone-Johnson","year":"2018","unstructured":"E.R. Bertone-Johnson, J.E. Manson, A.C. Purdue-Smithe, A.Z. Steiner, A.H. Eliassen, S.E. Hankinson, B.A. Rosner, B.W. Whitcomb, Anti-m\u00fcllerian hormone levels and incidence of early natural menopause in a prospective study. Hum. Reprod. 33(6), 1175\u20131182 (2018). https:\/\/doi.org\/10.1093\/humrep\/dey077.","journal-title":"Hum. Reprod."},{"issue":"8","key":"4265_CR95","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/GME.0000000000000642","volume":"23","author":"MR Gohari","year":"2016","unstructured":"M.R. Gohari, F. Ramezani Tehrani, S. Chenouri, M. Solaymani-Dodaran, F. Azizi, Individualized predictions of time to menopause using multiple measurements of antim\u00fcllerian hormone. Menopause 23(8), 839\u2013845 (2016). https:\/\/doi.org\/10.1097\/GME.0000000000000642.","journal-title":"Menopause"},{"issue":"4","key":"4265_CR96","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/gme.0b013e318193e95d","volume":"16","author":"FR Tehrani","year":"2009","unstructured":"F.R. Tehrani, M. Solaymani-Dodaran, F. Azizi, A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause 16(4), 797\u2013802 (2009). https:\/\/doi.org\/10.1097\/gme.0b013e318193e95d.","journal-title":"Menopause"},{"issue":"5","key":"4265_CR97","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1210\/jc.2011-3032","volume":"97","author":"EW Freeman","year":"2012","unstructured":"E.W. Freeman, M.D. Sammel, H. Lin, C.R. Gracia, Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J. Clin. Endocrinol. Metab. 97(5), 1673\u20131680 (2012). https:\/\/doi.org\/10.1210\/jc.2011-3032.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4265_CR98","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3109\/13697137.2014.898264","volume":"17","author":"F Ramezani Tehrani","year":"2014","unstructured":"F. Ramezani Tehrani, M. D\u00f3lleman, J. van Disseldorp, S.L. Broer, F. Azizi, M. Solaymani-Dodaran, B.C. Fauser, J.S.E. Laven, M.J.C. Eijkemans, F. Broekmans, Predicting menopausal age with anti-m\u00fcllerian hormone: a cross-validation study of two existing models. Climacteric: J. Int. Menopause Soc. 17(5), 583\u2013590 (2014). https:\/\/doi.org\/10.3109\/13697137.2014.898264.","journal-title":"Climacteric: J. Int. Menopause Soc."},{"issue":"2","key":"4265_CR99","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/GME.0000000000000509","volume":"23","author":"M Depmann","year":"2016","unstructured":"M. Depmann, S.L. Broer, Y.T. van der Schouw, F.R. Tehrani, M.J. Eijkemans, B.W. Mol, F.J. Broekmans, Can we predict age at natural menopause using ovarian reserve tests or mother\u2019s age at menopause? a systematic literature review. Menopause 23(2), 224\u2013232 (2016). https:\/\/doi.org\/10.1097\/GME.0000000000000509.","journal-title":"Menopause"},{"issue":"8","key":"4265_CR100","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1210\/jc.2010-2776","volume":"96","author":"SL Broer","year":"2011","unstructured":"S.L. Broer, M.J.C. Eijkemans, G.J. Scheffer, I.A.J. van Rooij, A. de Vet, A.P.N. Themmen, J.S.E. Laven, F.H. de Jong, E.R. Te Velde, B.C. Fauser, F.J.M. Broekmans, Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J. Clin. Endocrinol. Metab. 96(8), 2532\u20132539 (2011). https:\/\/doi.org\/10.1210\/jc.2010-2776.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"4265_CR101","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.fertnstert.2011.02.057","volume":"95","author":"B Almog","year":"2011","unstructured":"B. Almog, F. Shehata, S. Suissa, H. Holzer, E. Shalom-Paz, A. La Marca, S. Muttukrishna, A. Blazar, R. Hackett, S.M. Nelson, J.S. Cunha-Filho, T. Eldar-Geva, E.J. Margalioth, N. Raine-Fenning, K. Jayaprakasan, M. McIlveen, D. Wunder, T. Freour, L.G. Nardo, T. Tulandi, Age-related normograms of serum antim\u00fcllerian hormone levels in a population of infertile women: a multicenter study. Fertil. Steril. 95(7), 2359\u20132363, 2363.e1 (2011). https:\/\/doi.org\/10.1016\/j.fertnstert.2011.02.057.","journal-title":"Fertil. Steril."},{"issue":"Pt 4","key":"4265_CR102","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1258\/acb.2011.010172","volume":"48","author":"AM Wallace","year":"2011","unstructured":"A.M. Wallace, S.A. Faye, R. Fleming, S.M. Nelson, A multicentre evaluation of the new Beckman Coulter anti-mullerian hormone immunoassay (AMH Gen II). Ann. Clin. Biochem. 48(Pt 4), 370\u2013373 (2011). https:\/\/doi.org\/10.1258\/acb.2011.010172.","journal-title":"Ann. Clin. Biochem."},{"issue":"11","key":"4265_CR103","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1210\/jc.2018-02607","volume":"104","author":"AC de Kat","year":"2019","unstructured":"A.C. de Kat, Y.T. van der Schouw, M.J.C. Eijkemans, S.L. Broer, W.M.M. Verschuren, F.J.M. Broekmans, Can menopause prediction be improved with multiple AMH measurements? results from the prospective doetinchem cohort study. J. Clin. Endocrinol. Metab. 104(11), 5024\u20135031 (2019). https:\/\/doi.org\/10.1210\/jc.2018-02607.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4265_CR104","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.fertnstert.2012.07.1139","volume":"98","author":"EW Freeman","year":"2012","unstructured":"E.W. Freeman, M.D. Sammel, H. Lin, D.W. Boorman, C.R. Gracia, Contribution of the rate of change of antim\u00fcllerian hormone in estimating time to menopause for late reproductive-age women. Fertil. Steril. 98(5), 1254\u20131259.e1-2 (2012). https:\/\/doi.org\/10.1016\/j.fertnstert.2012.07.1139.","journal-title":"Fertil. Steril."},{"issue":"11","key":"4265_CR105","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13259","volume":"19","author":"F Amargant","year":"2020","unstructured":"F. Amargant, S.L. Manuel, Q. Tu, W.S. Parkes, F. Rivas, L.T. Zhou, J.E. Rowley, C.E. Villanueva, J.E. Hornick, G.S. Shekhawat, J.-J. Wei, M.E. Pavone, A.R. Hall, M.T. Pritchard, F.E. Duncan, Ovarian stiffness increases with age in the mammalian ovary and depends on collagen and hyaluronan matrices. Aging Cell 19(11), e13259 (2020). https:\/\/doi.org\/10.1111\/acel.13259.","journal-title":"Aging Cell"},{"issue":"4","key":"4265_CR106","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.3892\/etm.2018.6592","volume":"16","author":"S Sun","year":"2018","unstructured":"S. Sun, H. Chen, X. Zheng, C. Ma, R. Yue, Analysis on the level of IL-6, IL-21, AMH in patients with auto-immunity premature ovarian failure and study of correlation. Exp. Therapeutic Med. 16(4), 3395\u20133398 (2018). https:\/\/doi.org\/10.3892\/etm.2018.6592.","journal-title":"Exp. Therapeutic Med."},{"issue":"3","key":"4265_CR107","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/humrep\/der473","volume":"27","author":"S Kallio","year":"2012","unstructured":"S. Kallio, K. Aittom\u00e4ki, T. Piltonen, R. Veijola, A. Liakka, T.E. Vaskivuo, L. Dunkel, J.S. Tapanainen, Anti-mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries. Hum. Reprod. 27(3), 854\u2013860 (2012). https:\/\/doi.org\/10.1093\/humrep\/der473.","journal-title":"Hum. Reprod."},{"issue":"3","key":"4265_CR108","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.fertnstert.2011.06.016","volume":"96","author":"HWR Li","year":"2011","unstructured":"H.W.R. Li, R.A. Anderson, W.S.B. Yeung, P.C. Ho, E.H.Y. Ng, Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea. Fertil. Steril. 96(3), 774\u2013779 (2011). https:\/\/doi.org\/10.1016\/j.fertnstert.2011.06.016.","journal-title":"Fertil. Steril."},{"key":"4265_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.601752","volume":"12","author":"X Jiao","year":"2021","unstructured":"X. Jiao, T. Meng, Y. Zhai, L. Zhao, W. Luo, P. Liu, Y. Qin, Ovarian reserve markers in premature ovarian insufficiency: within different clinical stages and different etiologies. Front. Endocrinol. 12, 601752 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.601752.","journal-title":"Front. Endocrinol."},{"key":"4265_CR110","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejogrb.2020.10.053","volume":"256","author":"S Desongnis","year":"2021","unstructured":"S. Desongnis, G. Robin, D. Dewailly, P. Pigny, S. Catteau-Jonard, AMH assessment five or more years after an initially low AMH level. Eur. J. Obstet., Gynecol., Reprod. Biol. 256, 70\u201374 (2021). https:\/\/doi.org\/10.1016\/j.ejogrb.2020.10.053.","journal-title":"Eur. J. Obstet., Gynecol., Reprod. Biol."},{"issue":"11","key":"4265_CR111","doi-asserted-by":"publisher","first-page":"e0188334","DOI":"10.1371\/journal.pone.0188334","volume":"12","author":"Y Guzel","year":"2017","unstructured":"Y. Guzel, Y.A. Aba, K. Yakin, O. Oktem, Menstrual cycle characteristics of young females with occult primary ovarian insufficiency at initial diagnosis and one-year follow-up with serum amh level and antral follicle count. PLoS One 12(11), e0188334 (2017). https:\/\/doi.org\/10.1371\/journal.pone.0188334.","journal-title":"PLoS One"},{"issue":"5","key":"4265_CR112","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/13697137.2020.1868426","volume":"24","author":"SM Nelson","year":"2021","unstructured":"S.M. Nelson, R.A. Anderson, Prediction of premature ovarian insufficiency: foolish fallacy or feasible foresight?. Climacteric: J. Int. Menopause Soc. 24(5), 438\u2013443 (2021). https:\/\/doi.org\/10.1080\/13697137.2020.1868426.","journal-title":"Climacteric: J. Int. Menopause Soc."},{"issue":"1","key":"4265_CR113","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.fertnstert.2010.04.006","volume":"95","author":"KR Hansen","year":"2011","unstructured":"K.R. Hansen, G.M. Hodnett, N. Knowlton, L.B. Craig, Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil. Steril. 95(1), 170\u2013175 (2011). https:\/\/doi.org\/10.1016\/j.fertnstert.2010.04.006.","journal-title":"Fertil. Steril."},{"issue":"5","key":"4265_CR114","doi-asserted-by":"publisher","first-page":"515.e1","DOI":"10.1016\/j.ajog.2021.06.052","volume":"225","author":"E Hariton","year":"2021","unstructured":"E. Hariton, T.N. Shirazi, N.C. Douglas, A. Hershlag, S.F. Briggs, Anti-m\u00fcllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals. Am. J. Obstet. Gynecol. 225(5), 515.e1\u2013515.e10 (2021). https:\/\/doi.org\/10.1016\/j.ajog.2021.06.052.","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"4265_CR115","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/humrep\/15.1.24","volume":"15","author":"MW Elting","year":"2000","unstructured":"M.W. Elting, T.J. Korsen, L.T. Rekers-Mombarg, J. Schoemaker, Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum. Reprod. 15(1), 24\u201328 (2000). https:\/\/doi.org\/10.1093\/humrep\/15.1.24.","journal-title":"Hum. Reprod."},{"issue":"1","key":"4265_CR116","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/13697137.2017.1392501","volume":"21","author":"S Minooee","year":"2018","unstructured":"S. Minooee, F. Ramezani Tehrani, M. Rahmati, M.A. Mansournia, F. Azizi, Prediction of age at menopause in women with polycystic ovary syndrome. Climacteric: J. Int. Menopause Soc. 21(1), 29\u201334 (2018). https:\/\/doi.org\/10.1080\/13697137.2017.1392501.","journal-title":"Climacteric: J. Int. Menopause Soc."},{"key":"4265_CR117","doi-asserted-by":"crossref","unstructured":"Piltonen, TT, Komsi, E, Morin-Papunen, LC, Korhonen, E, Franks, S, J\u00e4rvelin, M-R, Arffman, RK, & Ollila, M-M (2023) AMH as part of the diagnostic PCOS workup in large epidemiological studies [Tutkimusartikkeli] JultikaOuluFi https:\/\/oulurepooulufi\/handle\/10024\/45881.","DOI":"10.1093\/ejendo\/lvad065"},{"issue":"1","key":"4265_CR118","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12905-022-01782-2","volume":"22","author":"MS Butt","year":"2022","unstructured":"M.S. Butt, J. Saleem, S. Aiman, R. Zakar, I. Sadique, F. Fischer, Serum anti-m\u00fcllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age. BMC Women\u2019s Health 22(1), 199 (2022). https:\/\/doi.org\/10.1186\/s12905-022-01782-2.","journal-title":"BMC Women\u2019s Health"},{"key":"4265_CR119","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12958-015-0134-9","volume":"13","author":"A Dumont","year":"2015","unstructured":"A. Dumont, G. Robin, S. Catteau-Jonard, D. Dewailly, Role of anti-m\u00fcllerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Reprod. Biol. Endocrinol.: RBE 13, 137 (2015). https:\/\/doi.org\/10.1186\/s12958-015-0134-9.","journal-title":"Reprod. Biol. Endocrinol.: RBE"},{"issue":"1","key":"4265_CR120","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","volume":"33","author":"D Garg","year":"2016","unstructured":"D. Garg, R. Tal, The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod. Biomedicine Online 33(1), 15\u201328 (2016). https:\/\/doi.org\/10.1016\/j.rbmo.2016.04.007.","journal-title":"Reprod. Biomedicine Online"},{"issue":"11","key":"4265_CR121","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1093\/humrep\/des274","volume":"27","author":"I Streuli","year":"2012","unstructured":"I. Streuli, D. de Ziegler, V. Gayet, P. Santulli, G. Bijaoui, J. de Mouzon, C. Chapron, In women with endometriosis anti-m\u00fcllerian hormone levels are decreased only in those with previous endometrioma surgery. Hum. Reprod. 27(11), 3294\u20133303 (2012). https:\/\/doi.org\/10.1093\/humrep\/des274.","journal-title":"Hum. Reprod."},{"issue":"8","key":"4265_CR122","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1093\/humrep\/det123","volume":"28","author":"G Uncu","year":"2013","unstructured":"G. Uncu, I. Kasapoglu, K. Ozerkan, A. Seyhan, A. Oral Yilmaztepe, B. Ata, Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum. Reprod. 28(8), 2140\u20132145 (2013). https:\/\/doi.org\/10.1093\/humrep\/det123.","journal-title":"Hum. Reprod."},{"issue":"3","key":"4265_CR123","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/humupd\/dmy049","volume":"25","author":"JS Younis","year":"2019","unstructured":"J.S. Younis, N. Shapso, R. Fleming, I. Ben-Shlomo, I. Izhaki, Impact of unilateral versus bilateral ovarian endometriotic cystectomy on ovarian reserve: a systematic review and meta-analysis. Hum. Reprod. Update 25(3), 375\u2013391 (2019). https:\/\/doi.org\/10.1093\/humupd\/dmy049.","journal-title":"Hum. Reprod. Update"},{"key":"4265_CR124","doi-asserted-by":"publisher","unstructured":"M.H. van den Berg, A. Overbeek, C.B. Lambalk, G.J.L. Kaspers, D. Bresters, M. M. van den Heuvel-Eibrink, L.C. Kremer, J.J. Loonen, H.J. van der Pal, C.M. Ronckers, W.J.E. Tissing, A.B. Versluys, M. van der Heiden-van der Loo, A.C. Heijboer, M. Hauptmann, J.W.R. Twisk, J.S.E. Laven, C.C.M. Beerendonk, F.E. van Leeuwen, Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve. Hum. Reprod. (Oxford, England) 33(8), 1474\u20131488 (2018). https:\/\/doi.org\/10.1093\/humrep\/dey229.","DOI":"10.1093\/humrep\/dey229"},{"key":"4265_CR125","doi-asserted-by":"publisher","unstructured":"S.N. Nielsen, A.N. Andersen, K.T. Schmidt, C. Rechnitzer, K. Schmiegelow, J.G. Bentzen, E.C. Larsen, A 10-year follow up of reproductive function in women treated for childhood cancer. Reprod. Biomed. Online 27(2), 192\u2013200 (2013). https:\/\/doi.org\/10.1016\/j.rbmo.2013.04.003.","DOI":"10.1016\/j.rbmo.2013.04.003"},{"issue":"1","key":"4265_CR126","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/humrep\/dew278","volume":"32","author":"ALF van der Kooi","year":"2017","unstructured":"A.L.F. van der Kooi, M.M. van den Heuvel-Eibrink, A. van Noortwijk, S.J.C.M.M. Neggers, S.M.F. Pluijm, E. van Dulmen-den Broeder, W. van Dorp, J.S.E. Laven, Longitudinal follow-up in female childhood cancer survivors: no signs of accelerated ovarian function loss. Hum. Reprod. 32(1), 193\u2013200 (2017). https:\/\/doi.org\/10.1093\/humrep\/dew278.","journal-title":"Hum. Reprod."},{"issue":"2","key":"4265_CR127","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/humrep\/det442","volume":"29","author":"W van Dorp","year":"2014","unstructured":"W. van Dorp, M.M. van den Heuvel-Eibrink, A.C.H. de Vries, S.M.F. Pluijm, J.A. Visser, R. Pieters, J.S.E. Laven, Decreased serum anti-m\u00fcllerian hormone levels in girls with newly diagnosed cancer. Hum. Reprod. 29(2), 337\u2013342 (2014). https:\/\/doi.org\/10.1093\/humrep\/det442.","journal-title":"Hum. Reprod."},{"issue":"7872","key":"4265_CR128","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-021-03779-7","volume":"596","author":"KS Ruth","year":"2021","unstructured":"K.S. Ruth, F.R. Day, J. Hussain, A. Mart\u00ednez-Marchal, C.E. Aiken, A. Azad, D.J. Thompson, L. Knoblochova, H. Abe, J.L. Tarry-Adkins, J.M. Gonzalez, P. Fontanillas, A. Claringbould, O.B. Bakker, P. Sulem, R.G. Walters, C. Terao, S. Turon, M. Horikoshi, J.R.B. Perry, Genetic insights into biological mechanisms governing human ovarian ageing. Nature 596(7872), 393\u2013397 (2021). https:\/\/doi.org\/10.1038\/s41586-021-03779-7.","journal-title":"Nature"},{"issue":"4\u201305","key":"4265_CR129","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1055\/s-0040-1721796","volume":"38","author":"JSE Laven","year":"2020","unstructured":"J.S.E. Laven, Genetics of menopause and primary ovarian insufficiency: time for a paradigm shift?. Semin. Reprod. Med. 38(4\u201305), 256\u2013262 (2020). https:\/\/doi.org\/10.1055\/s-0040-1721796.","journal-title":"Semin. Reprod. Med."},{"key":"4265_CR130","doi-asserted-by":"publisher","unstructured":"T. Porstmann, S.T. Kiessig, Enzyme immunoassay techniques. An overview. J. Immunol. Methods 150(1\u20132), 5\u201321 (1992). https:\/\/doi.org\/10.1016\/0022-1759(92)90061-w.","DOI":"10.1016\/0022-1759(92)90061-w"},{"issue":"5","key":"4265_CR131","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.rbmo.2018.08.012","volume":"37","author":"JM Ferguson","year":"2018","unstructured":"J.M. Ferguson, D. P\u00e9pin, C. Duru, P. Matejtschuk, P.K. Donahoe, C.J. Burns, Towards international standardization of immunoassays for m\u00fcllerian inhibiting substance\/anti-m\u00fcllerian hormone. Reprod. Biomedicine Online 37(5), 631\u2013640 (2018). https:\/\/doi.org\/10.1016\/j.rbmo.2018.08.012.","journal-title":"Reprod. Biomedicine Online"},{"issue":"3","key":"4265_CR132","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"D. Dewailly, C.Y. Andersen, A. Balen, F. Broekmans, N. Dilaver, R. Fanchin, G. Griesinger, T.W. Kelsey, A. La Marca, C. Lambalk, H. Mason, S.M. Nelson, J.A. Visser, W.H. Wallace, R.A. Anderson, The physiology and clinical utility of anti-mullerian hormone in women. Hum. Reprod. Update 20(3), 370\u2013385 (2014). https:\/\/doi.org\/10.1093\/humupd\/dmt062.","journal-title":"Hum. Reprod. Update"},{"key":"4265_CR133","doi-asserted-by":"publisher","unstructured":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, Fourth Edition. Carl A. Burtis, Edward R. Ashwood, and David E. Bruns, editors. St. Louis, MO: Elsevier Saunders, 2006, 2448 pp., $229.00, hardcover. Clinical Chemistry, Volume 52, Issue 6, 1 June 2006, Page 1214, https:\/\/doi.org\/10.1373\/clinchem.2005.062638.","DOI":"10.1373\/clinchem.2005.062638"},{"issue":"1","key":"4265_CR134","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12958-020-00641-9","volume":"18","author":"J Ferguson","year":"2020","unstructured":"J. Ferguson, J. Hockley, P. Rigsby, C. Burns, Establishment of a WHO reference reagent for anti-mullerian hormone. Reprod. Biol. Endocrinol.: RBE 18(1), 86 (2020). https:\/\/doi.org\/10.1186\/s12958-020-00641-9.","journal-title":"Reprod. Biol. Endocrinol.: RBE"},{"key":"4265_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.719029","volume":"12","author":"R Punchoo","year":"2021","unstructured":"R. Punchoo, S. Bhoora, Variation in the measurement of anti-m\u00fcllerian hormone\u2014what are the laboratory issues?. Front. Endocrinol. 12, 719029 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.719029.","journal-title":"Front. Endocrinol."},{"key":"4265_CR136","doi-asserted-by":"publisher","unstructured":"M.M. Lee, P.K. Donahoe, Mullerian inhibiting substance: A gonadal hormone with multiple functions. Endocr. Rev. 14(2), 152\u2013164 (1993). https:\/\/doi.org\/10.1210\/edrv-14-2-152.","DOI":"10.1210\/edrv-14-2-152"},{"issue":"10","key":"4265_CR137","doi-asserted-by":"publisher","first-page":"E1241","DOI":"10.1152\/ajpendo.00395.2013","volume":"305","author":"MW Pankhurst","year":"2013","unstructured":"M.W. Pankhurst, I.S. McLennan, Human blood contains both the uncleaved precursor of anti-mullerian hormone and a complex of the NH2- and COOH-terminal peptides. Am. J. Physiol. Endocrinol. Metab. 305(10), E1241\u2013E1247 (2013). https:\/\/doi.org\/10.1152\/ajpendo.00395.2013.","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"4265_CR138","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","volume":"105","author":"LME Moolhuijsen","year":"2020","unstructured":"L.M.E. Moolhuijsen, J.A. Visser, Anti-m\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function. J. Clin. Endocrinol. Metab. 105(11), 3361\u20133373 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa513.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4265_CR139","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.fertnstert.2014.02.046","volume":"101","author":"HI Su","year":"2014","unstructured":"H.I. Su, M.D. Sammel, M.V. Homer, K. Bui, C. Haunschild, F.Z. Stanczyk, Comparability of antim\u00fcllerian hormone levels among commercially available immunoassays. Fertil. Steril. 101(6), 1766\u20131772.e1 (2014). https:\/\/doi.org\/10.1016\/j.fertnstert.2014.02.046.","journal-title":"Fertil. Steril."},{"issue":"Pt 6","key":"4265_CR140","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/000456329903600603","volume":"36","author":"C Selby","year":"1999","unstructured":"C. Selby, Interference in immunoassay. Ann. Clin. Biochem. 36(Pt 6), 704\u2013721 (1999). https:\/\/doi.org\/10.1177\/000456329903600603.","journal-title":"Ann. Clin. Biochem."},{"issue":"6","key":"4265_CR141","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1373\/jalm.2017.024257","volume":"2","author":"PJ Colon","year":"2018","unstructured":"P.J. Colon, D.N. Greene, Biotin interference in clinical immunoassays. J. Appl. Lab. Med. 2(6), 941\u2013951 (2018). https:\/\/doi.org\/10.1373\/jalm.2017.024257.","journal-title":"J. Appl. Lab. Med."},{"issue":"1","key":"4265_CR142","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1515\/cclm-2019-0496","volume":"58","author":"KA Turner","year":"2019","unstructured":"K.A. Turner, B.J. Larson, N.C. Kreofsky, M.A.V. Willrich, J.A. Bornhorst, A. Algeciras-Schimnich, Assessment of complement interference in anti-m\u00fcllerian hormone immunoassays. Clin. Chem. Lab. Med. 58(1), e8\u2013e10 (2019). https:\/\/doi.org\/10.1515\/cclm-2019-0496.","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"4265_CR143","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/clinchem\/45.7.942","volume":"45","author":"LJ Kricka","year":"1999","unstructured":"L.J. Kricka, Human anti-animal antibody interferences in immunological assays. Clin. Chem. 45(7), 942\u2013956 (1999). https:\/\/doi.org\/10.1093\/clinchem\/45.7.942.","journal-title":"Clin. Chem."},{"key":"4265_CR144","doi-asserted-by":"publisher","unstructured":"S. Iliodromiti, B. Salje, D. Dewailly, C. Fairburn, R. Fanchin, R. Fleming, H.W.R. Li, K. Lukaszuk, E.H.Y. Ng, P. Pigny, T. Tadros, J. van Helden, R. Weiskirchen, S.M. Nelson, Non-equivalence of anti-M\u00fcllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing. Hum. Reprod. (Oxford, England) 32(8), 1710\u20131715 (2017). https:\/\/doi.org\/10.1093\/humrep\/dex219.","DOI":"10.1093\/humrep\/dex219"},{"issue":"4","key":"4265_CR145","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40291-015-0156-1","volume":"19","author":"ED Deeks","year":"2015","unstructured":"E.D. Deeks, Elecsys(\u00ae) AMH assay: a review in anti-m\u00fcllerian hormone quantification and assessment of ovarian reserve. Mol. Diagnosis Ther. 19(4), 245\u2013249 (2015). https:\/\/doi.org\/10.1007\/s40291-015-0156-1.","journal-title":"Mol. Diagnosis Ther."},{"key":"4265_CR146","volume-title":"Clinical Chemistry: Theory, Analysis, Correlation","author":"LA Kaplan","year":"2003","unstructured":"L.A. Kaplan, A.J. Pesce, S.C. Kazmierczak, in Clinical Chemistry: Theory, Analysis, Correlation (Mosby, St. Louis, 2003)."},{"issue":"7","key":"4265_CR147","doi-asserted-by":"publisher","first-page":"853","DOI":"10.17219\/acem\/121010","volume":"29","author":"M Kostrzewa","year":"2020","unstructured":"M. Kostrzewa, E. G\u0142owacka, T. Stetkiewicz, M. Grzesiak, K. Szy\u0142\u0142o, G. Stachowiak, J.R. Wilczy\u0144ski, Is serum anti-m\u00fcllerian hormone (AMH) assay a satisfactory measure for ovarian reserve estimation? A comparison of serum and peritoneal fluid AMH levels. Adv. Clin. Exp. Med. 29(7), 853\u2013856 (2020). https:\/\/doi.org\/10.17219\/acem\/121010.","journal-title":"Adv. Clin. Exp. Med."},{"issue":"6 Pt 1","key":"4265_CR148","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/01.gme.0000123642.76105.6e","volume":"11","author":"IAJ van Rooij","year":"2004","unstructured":"I.A.J. van Rooij, I. den Tonkelaar, F.J.M. Broekmans, C.W.N. Looman, G.J. Scheffer, F.H. de Jong, A.P.N. Themmen, E.R. te Velde, Anti-m\u00fcllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 11(6 Pt 1), 601\u2013606 (2004). https:\/\/doi.org\/10.1097\/01.gme.0000123642.76105.6e.","journal-title":"Menopause"},{"issue":"6","key":"4265_CR149","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1210\/jc.2007-2093","volume":"93","author":"J van Disseldorp","year":"2008","unstructured":"J. van Disseldorp, M.J. Faddy, A.P.N. Themmen, F.H. de Jong, P.H.M. Peeters, Y.T. van der Schouw, F.J.M. Broekmans, Relationship of serum antim\u00fcllerian hormone concentration to age at menopause. J. Clin. Endocrinol. Metab. 93(6), 2129\u20132134 (2008). https:\/\/doi.org\/10.1210\/jc.2007-2093.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"4265_CR150","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1210\/jc.2008-0567","volume":"93","author":"MR Sowers","year":"2008","unstructured":"M.R. Sowers, A.D. Eyvazzadeh, D. McConnell, M. Yosef, M.L. Jannausch, D. Zhang, S. Harlow, J.F. Randolph, Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J. Clin. Endocrinol. Metab. 93(9), 3478\u20133483 (2008). https:\/\/doi.org\/10.1210\/jc.2008-0567.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"4265_CR151","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/gme.0b013e318205e2ac","volume":"18","author":"FR Tehrani","year":"2011","unstructured":"F.R. Tehrani, N. Shakeri, M. Solaymani-Dodaran, F. Azizi, Predicting age at menopause from serum antim\u00fcllerian hormone concentration. Menopause 18(7), 766\u2013770 (2011). https:\/\/doi.org\/10.1097\/gme.0b013e318205e2ac.","journal-title":"Menopause"},{"issue":"2","key":"4265_CR152","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1210\/jc.2012-3176","volume":"98","author":"FR Tehrani","year":"2013","unstructured":"F.R. Tehrani, M. Solaymani-Dodaran, M. Tohidi, M.R. Gohari, F. Azizi, Modeling age at menopause using serum concentration of anti-mullerian hormone. J. Clin. Endocrinol. Metab. 98(2), 729\u2013735 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3176.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4265_CR153","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/gme.0b013e3182611574","volume":"20","author":"K Iino","year":"2013","unstructured":"K. Iino, A. Tarakida, K. Abe, R. Taniguchi, T. Higuchi, I. Takahashi, H. Mizunuma, Role of antim\u00fcllerian hormone as a biomarker of the menopausal transition. Menopause 20(2), 218\u2013222 (2013). https:\/\/doi.org\/10.1097\/gme.0b013e3182611574.","journal-title":"Menopause"},{"issue":"4","key":"4265_CR154","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.maturitas.2015.06.026","volume":"81","author":"S Nair","year":"2015","unstructured":"S. Nair, J.C. Slaughter, J.G. Terry, D. Appiah, I. Ebong, E. Wang, D.S. Siscovick, B. Sternfeld, P.J. Schreiner, C.E. Lewis, E.K. Kabagambe, M.F. Wellons, Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: the CARDIA Women\u2019s Study. Maturitas 81(4), 493\u2013498 (2015). https:\/\/doi.org\/10.1016\/j.maturitas.2015.06.026.","journal-title":"Maturitas"},{"issue":"8","key":"4265_CR155","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/humrep\/dev145","volume":"30","author":"M D\u00f3lleman","year":"2015","unstructured":"M. D\u00f3lleman, W.M.M. Verschuren, M.J.C. Eijkemans, F.J.M. Broekmans, Y.T. van der Schouw, Added value of anti-m\u00fcllerian hormone in prediction of menopause: results from a large prospective cohort study. Hum. Reprod. 30(8), 1974\u20131981 (2015). https:\/\/doi.org\/10.1093\/humrep\/dev145.","journal-title":"Hum. Reprod."},{"issue":"6","key":"4265_CR156","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/GME.0000000000000599","volume":"23","author":"F Ramezani Tehrani","year":"2016","unstructured":"F. Ramezani Tehrani, M.A. Mansournia, M. Solaymani-Dodaran, E. Steyerberg, F. Azizi, Flexible parametric survival models built on age-specific antim\u00fcllerian hormone percentiles are better predictors of menopause. Menopause 23(6), 676\u2013681 (2016). https:\/\/doi.org\/10.1097\/GME.0000000000000599.","journal-title":"Menopause"},{"issue":"10","key":"4265_CR157","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1210\/jc.2018-01110","volume":"103","author":"BW Whitcomb","year":"2018","unstructured":"B.W. Whitcomb, A. Purdue-Smithe, S.E. Hankinson, J.E. Manson, B.A. Rosner, E.R. Bertone-Johnson, Menstrual cycle characteristics in adolescence and early adulthood are associated with risk of early natural menopause. J. Clin. Endocrinol. Metab. 103(10), 3909\u20133918 (2018). https:\/\/doi.org\/10.1210\/jc.2018-01110.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4265_CR158","doi-asserted-by":"publisher","first-page":"dgaa083","DOI":"10.1210\/clinem\/dgaa083","volume":"105","author":"F Ramezani Tehrani","year":"2020","unstructured":"F. Ramezani Tehrani, R. Bidhendi Yarandi, M. Solaymani-Dodaran, M. Tohidi, F. Firouzi, F. Azizi, Improving prediction of age at menopause using multiple anti-m\u00fcllerian hormone measurements: the tehran lipid-glucose study. J. Clin. Endocrinol. Metab. 105(5), dgaa083 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa083.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4265_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.727229","volume":"12","author":"F Ramezani Tehrani","year":"2021","unstructured":"F. Ramezani Tehrani, A. Sheidaei, F. Firouzi, M. Tohidi, F. Azizi, S. Behboudi-Gandevani, Does the anti-mullerian hormone decline rate improve the prediction of age at menopause?. Front. Endocrinol. 12, 727229 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.727229.","journal-title":"Front. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04265-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04265-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04265-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:12:07Z","timestamp":1753369927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04265-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":159,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4265"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04265-0","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}